Acalabrutinib - Acerta Pharma/AstraZeneca
At a glance
- Drug Originator Acerta Pharma
- Drug Licenced by Biologics Inc
- Drug Class Anti-infectives; Antineoplastics; Antirheumatics; Benzamides; Heavy metals; Imidazoles; Pyrazines; Pyridines; Pyrrolidines; Small molecules
- Mechanism of Action Agammaglobulinaemia tyrosine kinase inhibitors
- USA Patent Applicants ASTRAZENECA
- USA Patents 15
- NDAs 2
- International Patents 179
- Patent Applications 571
Table of Contents

Disclaimer